Home
News
Government
Health & Social Care
Coronavirus (COVID-19)
Cancer Research
Diseases & Conditions
Mental Health
Pharma
Women’s Health
Environment
Circular Economy
Sustainable Development
Agriculture
Energy
Research & Innovation
Transport
Education
Finance
Workplace
Technology
Digital Transformation
Blockchain
Publications
Special Reports
Government
Health & Social Care
Environment
Energy
Research & Innovation
Transport
Education
Finance
HR & Training
Technology
Stakeholders
Government
Blockchain
Health & Social Care
Environment
Energy
Research & Innovation
Transport
Education
Finance
HR & Training
Technology
eBooks
Government
Blockchain
Health & Social Care
Environment
Energy
Research & Innovation
Transport
Education
Finance
HR & Training
Technology
North America Analysis
Asia Analysis
Subscribe
Search
Monday, January 18, 2021
Contact Us
About Us
Editors
Our Audience
Marketing Information Pack
Prestige Contributors
Testimonials
Open Access Government
Home
News
Government
Health & Social Care
Coronavirus (COVID-19)
Cancer Research
Diseases & Conditions
Mental Health
Pharma
Women’s Health
Environment
Circular Economy
Sustainable Development
Agriculture
Energy
Research & Innovation
Transport
Education
Finance
Workplace
Technology
Digital Transformation
Blockchain
Publications
Special Reports
Government
Health & Social Care
Environment
Energy
Research & Innovation
Transport
Education
Finance
HR & Training
Technology
Stakeholders
Government
Blockchain
Health & Social Care
Environment
Energy
Research & Innovation
Transport
Education
Finance
HR & Training
Technology
eBooks
Government
Blockchain
Health & Social Care
Environment
Energy
Research & Innovation
Transport
Education
Finance
HR & Training
Technology
North America Analysis
Asia Analysis
Subscribe
Government
Health
Environment
Agriculture
Energy
Research
Transport
Education
Finance
Workplace
Technology
North America
Asia
Home
John Lucas - Oxford Cannabinoid Technologies
John Lucas
Chief Commercial Officer
Oxford Cannabinoid Technologies
LEAVE A REPLY
Cancel reply
Please enter your comment!
Please enter your name here
You have entered an incorrect email address!
Please enter your email address here
Save my name, email, and website in this browser for the next time I comment.
Contributor's Details
Phone:
+44 (0)1865 304 040
Email:
press@oxcantech.com
Website:
Visit Website
Twitter:
Follow on Twitter
Contributor's Articles
Cannabinoids in medicine Part 1: Cancer
Cannabinoids in medicine Part 2: Pain
Cannabinoids in Medicine Part 3: Psoriasis and Rheumatoid Arthritis
Cannabinoids in medicine part 4: Epilepsy
Cannabinoids in medicine part 5: Treating COVID-19
Please Choose
Search Everything
Articles
eBooks
Publications
Special Reports
Stakeholders
The Open Access Government site uses cookies,
Find out more.
Okay, thanks